Cyclosporin increases cellular idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearance

Publication year

2001

Author(s)

Raymakers, R.A.P.

Linssen, P.C.M.

Witte, T.J.M. de

Source

Leukemia, 15, 1, (2001), pp. 80-88

ISSN

DOI

https://doi.org/10.1038/sj.leu.2401996

Publication type

Article / Letter to editor

Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/188625

https://hdl.handle.net/2066/188625

Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.